fintech / news / / The Guardian
Ethics filings revealed several thousand trades on the US president’s behalf tied to stocks and bonds in the first quarter of 2026.
Trump's financial disclosures show hundreds of thousands invested in Eli Lilly during Q1 2026.
KEY POINTS
- Seven purchases of Eli Lilly shares worth up to $680,000 coincided with federal actions benefitting the company.
- New Medicare pilot program under Trump expanded access to Lilly’s GLP-1 obesity medications.
- TrumpRx, launched in February, directed patients to Eli Lilly’s telemedicine service and featured their drugs.
- Trump's 2026 transaction volume far exceeded his trading activity from the first year of his second term.
COMPANIES
Summarized by Newsio from The Guardian. How we summarize →